Deciphera Pharmaceuticals Inc (DCPH)
25.45
+0.01
(+0.04%)
USD |
NASDAQ |
May 15, 16:00
25.45
0.00 (0.00%)
After-Hours: 16:02
Deciphera Pharmaceuticals Free Cash Flow: -152.39M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -152.39M |
| December 31, 2023 | -147.48M |
| September 30, 2023 | -153.74M |
| June 30, 2023 | -145.27M |
| March 31, 2023 | -152.17M |
| December 31, 2022 | -153.70M |
| September 30, 2022 | -184.63M |
| June 30, 2022 | -223.24M |
| March 31, 2022 | -229.83M |
| December 31, 2021 | -246.79M |
| September 30, 2021 | -230.28M |
| June 30, 2021 | -220.85M |
| March 31, 2021 | -232.28M |
| Date | Value |
|---|---|
| December 31, 2020 | -245.00M |
| September 30, 2020 | -253.00M |
| June 30, 2020 | -228.58M |
| March 31, 2020 | -202.22M |
| December 31, 2019 | -154.23M |
| September 30, 2019 | -123.84M |
| June 30, 2019 | -122.84M |
| March 31, 2019 | -104.11M |
| December 31, 2018 | -87.91M |
| September 30, 2018 | -73.62M |
| June 30, 2018 | -57.54M |
| March 31, 2018 | -46.50M |
| December 31, 2017 | -37.11M |
Free Cash Flow Range, Past 5 Years
-253.00M
Minimum
Sep 2020
-122.84M
Maximum
Jun 2019
-190.12M
Average
-193.43M
Median
Free Cash Flow Benchmarks
| Bristol-Myers Squibb Co | 12.51B |
| Dynavax Technologies Corp | 52.69M |
| Gilead Sciences Inc | 7.90B |
| Esperion Therapeutics Inc | -27.38M |
| SINTX Technologies Inc | -14.64M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -54.58M |
| Cash from Investing (Quarterly) | 62.63M |
| Cash from Financing (Quarterly) | 0.522M |
| Free Cash Flow Per Share (Quarterly) | -0.6263 |
| Free Cash Flow to Equity (Quarterly) | -54.73M |
| Free Cash Flow Yield | -6.94% |